Sage Therapeutics Looks to File NDA for Postpartum Depression Treatment Later This Year

By January 11, 2018 BioPharma No Comments

During the J.P. Morgan Healthcare Conference, Sage provided an update on its long-term strategy to drive growth at the company.
Source: BioSpace